1-3 of 3
Waiyi Zou
Close
Sort by
Journal Articles

Patient-Versus Physician-Perceptions of Symptoms, Treatment and Management in Chronic Myeloid Leukemia

Hong Chen, Yan Wen, Yun Zeng, LiE Lin, Xin Du, Zhenfang Liu, Bihong Sun, Hongqian Zhu, Huiqing He, Xiaotao Wang, Waiyi Zou, Caifeng Zheng, Liling Zheng, Jinxiong Huang, Liping Pang, Jixian Huang, Yuming Zhang, Haiqing Lin, Zelin Liu, Wanshou Zhu, Xuan Zhou, Qiang Wang, Xiaoli Liu, Qifa Liu, Na Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10841–10842.
https://doi.org/10.1182/blood-2022-157246
Published: 2022
Journal Articles

Favorable Inductive Remission Rate of Decitabine Combined Chemotherapy on < 60-Years of Age MDS-like AML in the First Course

Fengqi Liu, MD, Xiuzhen Tong, MD, Zhenhai Zhou, MD, Dong Zheng, MD, Hehua Wang, MD, Junru Liu, MD, Beihui Huang, MD, Chang Su, MD, Waiyi Zou, MD, Duorong Xu, MD, Juan Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2711.
https://doi.org/10.1182/blood-2018-99-113748
Published: 2018
Journal Articles

Bortezomib with Dexamethasone in Newly Diagnosed Patients with Primary Systemic Light Chain Amyloidosis or Multiple Myeloma-Associated AL Amyloidosis

Beihui Huang, M.D., Juan Li, MD, PhD, Junru Liu, M.D., Dong Zheng, MD, PhD, Mei Chen, M.D., Zhenhai Zhou, M.D., Duorong Xu, M.D., Waiyi Zou, M.D.
Journal: Blood
Blood (2012) 120 (21): 5036.
https://doi.org/10.1182/blood.V120.21.5036.5036
Published: 2012